<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Advisory Committee; Nonprescription Drugs Advisory Committee; Renewal</title>
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <style>
        body { font-family: Arial, sans-serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { color: #333; }
        .metadata { color: #666; font-size: 0.9em; }
        .summary { margin-top: 20px; line-height: 1.5; }
        .source { margin-top: 20px; }
    </style>
</head>
<body>
    <h1>Advisory Committee; Nonprescription Drugs Advisory Committee; Renewal</h1>
    <div class="metadata">Published: 2026-02-05 12:24:29</div>
    <div class="summary">The Food and Drug Administration (FDA) is announcing the renewal of the Nonprescription Drugs Advisory Committee by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the Nonprescription Drugs Advisory Committee for an additional 2 years beyond the charter expiration date. The new charter will be in effect until the August 27, 2025, expiration date.</div>
    <div class="source">Source: <a href="https://www.federalregister.gov/documents/2023/11/15/2023-25100/advisory-committee-nonprescription-drugs-advisory-committee-renewal" target="_blank" rel="noopener noreferrer">https://www.federalregister.gov/documents/2023/11/15/2023-25100/advisory-committee-nonprescription-drugs-advisory-committee-renewal</a></div>
</body>
</html>
